Tabulong, Janeth A.

HRN: 27-49-04  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/30/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/30/2025
08/31/2025
IV
4.5
Q6
Pleural Effusion
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines